ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
13.98
+1.68 (13.66%)
Sep 5, 2025, 4:08 PM HKT

HKG:1541 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
5,6942,10211,187--
Market Cap Growth
-5.48%-81.21%---
Enterprise Value
5,0911,65510,650--
Last Close Price
13.985.1629.90--
PS Ratio
42.3124.831319.67--
PB Ratio
9.732.9113.57--
P/TBV Ratio
9.722.9113.57--
EV/Sales Ratio
37.8219.561256.23--
Debt / Equity Ratio
0.290.200.100.02-0.01
Asset Turnover
0.160.090.010.01-
Quick Ratio
3.293.515.2612.300.27
Current Ratio
3.334.045.9312.600.28
Return on Equity (ROE)
-53.53%-44.38%-49.68%--
Return on Assets (ROA)
-25.66%-21.43%-26.59%-26.29%-
Return on Capital (ROIC)
-28.04%-23.51%-28.19%--
Earnings Yield
-5.82%-15.99%-3.74%--
FCF Yield
--7.01%-3.65%--
Buyback Yield / Dilution
-6.17%-4.24%-9.05%-284.99%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.